Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
3,706.75
+16.50(+0.45%)
Dow Futures
29,639.00
+101.00(+0.34%)
Nasdaq Futures
11,357.00
+71.25(+0.63%)
Russell 2000 Futures
1,724.00
+9.10(+0.53%)
Crude Oil
83.82
+0.19(+0.23%)
Gold
1,704.40
+2.40(+0.14%)

Advertisement

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

70.53

-0.56

(-0.79%)

At close: 04:00PM EDT

70.69

+0.16

(+0.23%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	71.09
Open	71.36
Bid	70.28 x 800
Ask	71.25 x 1200
Day's Range	69.39 - 71.51
52 Week Range	53.22 - 80.59
Volume	12,067,093
Avg. Volume	9,719,071

Market Cap	156.551B
Beta (5Y Monthly)	0.44
PE Ratio (TTM)	N/A
EPS (TTM)	-2.76
Earnings Date	Oct 26, 2022
Forward Dividend & Yield	2.16 (2.93%)
Ex-Dividend Date	Jun 30, 2022
1y Target Est	81.38

All

Investor's Business Daily
5 NYSE Stocks To Watch And Buy: Here Are Fundamental And Technical Reasons Why
Based on Monday's view of an IBD-produced screen, they now include small-cap enterprise software firm Model N, lithium metal producer Albemarle, electrical equipment firm Hubbell and trendy footwear and apparel firm Deckers Outdoor. In 2022, the NYSE's composite index continues to outperform its Nasdaq sibling. Since the November 2021 peak in the market, the NYSE composite has fallen as much as 20% from its 17,442 peak.
- Cybersecurity Stocks To Watch: Will Federal Spending Be A Bright Spot?
  Investor's Business Daily
- Daqo Stock Off Low; Profits Soar, Big Funds Haven't Noticed Yet
  Investor's Business Daily
Zacks
Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?
Bristol Myers (BMY) expects recent drug approvals to generate an incremental stream of revenues and combat competition for its key drugs.
Simply Wall St.
With 78% institutional ownership, Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst the big guns
If you want to know who really controls Bristol-Myers Squibb Company ( NYSE:BMY ), then you'll have to look at the...
- Positive week for Royal Gold, Inc. (NASDAQ:RGLD) institutional investors who lost 0.4% over the past year
  Simply Wall St.
- Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 81%
  Simply Wall St.

Advertisement

S&P Futures3,706.75+16.50(+0.45%)

Dow Futures29,639.00+101.00(+0.34%)

Nasdaq Futures11,357.00+71.25(+0.63%)

Russell 2000 Futures1,724.00+9.10(+0.53%)

Crude Oil83.82+0.19(+0.23%)

Gold1,704.40+2.40(+0.14%)

Bristol-Myers Squibb Company (BMY)

Chart Events

Performance Outlook

5 NYSE Stocks To Watch And Buy: Here Are Fundamental And Technical Reasons Why

Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?

With 78% institutional ownership, Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst the big guns

S&P Futures
3,706.75
+16.50(+0.45%)

Dow Futures
29,639.00
+101.00(+0.34%)

Nasdaq Futures
11,357.00
+71.25(+0.63%)

Russell 2000 Futures
1,724.00
+9.10(+0.53%)

Crude Oil
83.82
+0.19(+0.23%)

Gold
1,704.40
+2.40(+0.14%)